BiocardiaBCDA

13F holders, Q1 2025 (March 31)
12holders −1
2new positions
2sold out
$2.54avg. 13F price*

At the end of Q1 2025, 12 institutions reported holding Biocardia Inc. (BCDA) in their 13F filings, down 1 from Q4 2024. 2 opened new positions and 2 sold out. The largest holders were CM Management, LLC ($191K), Susquehanna International Group, LLP ($152K) and Geode Capital Management, LLC ($95K).

Company
Biocardia Inc.
CUSIP
09060U606
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q2 2024: 9Q2 2024Q3 2024: 9Q3 2024Q4 2024: 13Q4 2024Q1 2025: 12Q1 2025Q2 2025: 16Q2 2025Q3 2025: 18Q3 2025Q4 2025: 20Q4 2025Q1 2026: 18Q1 2026Q2 2026: 21Q2 2026

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions2$130K
Exits2$3K

All 13F filers, Q4 2024 → Q1 2025: 123,475 shares bought and 2,500 shares sold, net +120,975 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 12 holders

CM Management, LLC 0.19% Add +200.0% 75,000 $191K
Susquehanna International Group, LLP 0.00% Add +36.7% 59,949 $152K
Geode Capital Management, LLC 0.00% Add +20.1% 37,231 $95K
Brown Advisory Inc. 0.00% New 35,538 $90K
Commonwealth Equity Services, LLC 0.00% New 15,583 $40K
Vanguard Group Inc. 0.00% No change 12,884 $33K
UBS Group AG 0.00% Reduce -3.1% 4,602 $12K
Morgan Stanley 0.00% Reduce -22.7% 3,105 $8K
Pingora Partners LLC 0.00% No change 1,036 $3K
Bank of America Corp. 0.00% Add +0.5% 415 $1K
Osaic Holdings, Inc. 0.00% Add +1.6% 62 $157
SBI Securities Co., Ltd. 0.00% Reduce -46.7% 8 $20

"% of holder's portfolio" is BCDA's weight in each manager's 13F, not the share of Biocardia Inc. the manager owns.